Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
CNS Drugs|December 12, 2001
Third-generation antidepressants: do they offer advantages over the SSRIs?J S Olver, G D Burrows, T R NormanThe Australian and New Zealand Journal of Psychiatry|February 24, 2001
Pindolol augmentation of antidepressants: a review and rationaleJ S Olver, J F Cryan, G D Burrows, et al.International Journal of Psychiatry in Clinical Practice|June 19, 2014
Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindololJ S Olver, G D BurrowsJournal of Neural Transmission. Supplementum|January 1, 1989
Monoamine oxidase, monoamine oxidase inhibitors, and panic disorderT R Norman, G D BurrowsDrug Safety|January 1, 1995
A risk-benefit assessment of moclobemide in the treatment of depressive disordersT R Norman, G D BurrowsProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Plasma concentrations of benzodiazepines--a review of clinical findings and implicationsT R Norman, G D BurrowsEuropean Journal of Pharmacology|October 17, 1998
Neurochemical effects of the enantiomers of mirtazapine in normal ratsC McGrath, G D Burrows, T R NormanThe Medical Journal of Australia|July 25, 1981
Multicentre evaluation of mianserin in depressive illnessP Marriott, G D Burrows, T R NormanJournal of Chromatography. B, Biomedical Sciences and Applications|November 22, 2000
Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatographyS Dodd, G D Burrows, T R NormanInternational Clinical Psychopharmacology|April 1, 1990
Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolamT R Norman, G D Burrows, I M McIntyrePageof 20